Stockreport

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Evogene Ltd. - Ordinary Shares  (EVGN) 
Last evogene ltd. - ordinary shares earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: evogene.com/investor-relations
PDF LAV321demonstrated strong results in its third consecutive year of field trials in Europe REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-bio [Read more]